According to TRxADE HEALTH's latest financial reports and stock price the company's current price-to-sales ratio (TTM) is 0.1560. At the end of 2024 the company had a P/S ratio of 5.45.
Year | P/S ratio | Change |
---|---|---|
2024 | 5.45 | 203.29% |
2023 | 1.80 | 432.12% |
2022 | 0.3379 | -82.66% |
2021 | 1.95 | -22.06% |
2020 | 2.50 | -56.92% |
2019 | 5.80 | 122.71% |
2018 | 2.61 | -46.11% |
2017 | 4.84 | |
2016 | N/A | -100% |
2015 | 6.93 | -80.5% |
2014 | 35.5 | |
2009 | N/A |